T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBT
2176
Beacon Financial Corp
BBT
$2.71B
| $309K | ﹤0.01% |
20,815
+269
| +1% | +$6.79K |
|
2177
Evolent Health
EVH
$485M
| $309K | ﹤0.01% |
56,842
+787
| +1% | +$7.03K |
|
2178
West Bancorporation
WTBA
$511M
| $309K | ﹤0.01% |
18,910
+100
| +0.5% | +$2.16K |
|
|
AMAG
2179
DELISTED
AMAG Pharmaceuticals
AMAG
| $309K | ﹤0.01% |
50,031
+16,110
| +47% | +$142K |
|
2180
Inovio Pharmaceuticals
INO
$94.6M
| $308K | ﹤0.01% |
3,447
+1,919
| +126% | +$118K |
|
|
SAVE
2181
DELISTED
Spirit Airlines, Inc.
SAVE
| $308K | ﹤0.01% |
23,858
-6,728
| -22% | -$216K |
|
|
POLY
2182
DELISTED
Plantronics, Inc.
POLY
| $308K | ﹤0.01% |
30,615
-173,648
| -85% | -$3.24M |
|
2183
iShares MSCI Sweden ETF
EWD
$584M
| $305K | ﹤0.01% |
11,900
+5,200
| +78% | +$158K |
|
|
COOP
2184
DELISTED
Mr. Cooper
COOP
| $303K | ﹤0.01% |
41,372
+483
| +1% | +$5.59K |
|
2185
Protagonist Therapeutics
PTGX
$9.93B
| $301K | ﹤0.01% |
42,616
+100
| +0.2% | +$749 |
|
2186
VirnetX Holding Corp
VHC
$67.6M
| $301K | ﹤0.01% |
2,754
+1,121
| +69% | +$106K |
|
2187
Heartland Express
HTLD
$984M
| $300K | ﹤0.01% |
16,171
+251
| +2% | +$4.77K |
|
2188
SITE Centers
SITC
$158M
| $299K | ﹤0.01% |
73,629
+263
| +0.4% | +$2.28K |
|
|
FSP
2189
Franklin Street Properties
FSP
$46.8M
| $295K | ﹤0.01% |
51,566
+620
| +1% | +$4.39K |
|
2190
Bloomin' Brands
BLMN
$941M
| $294K | ﹤0.01% |
41,184
-131,348
| -76% | -$2.29M |
|
|
SPTN
2191
DELISTED
SpartanNash
SPTN
| $294K | ﹤0.01% |
20,516
+5,253
| +34% | +$67.6K |
|
|
ZEUS
2192
DELISTED
Olympic Steel
ZEUS
| $293K | ﹤0.01% |
28,280
| – | – |
|
|
CBB
2193
PUT
DELISTED
Cincinnati Bell Inc.
CBB
| $293K | ﹤0.01% |
+20,000
| New | +$260K |
|
2194
AAR Corp
AIR
$5.84B
| $292K | ﹤0.01% |
16,462
+6,759
| +70% | +$247K |
|
2195
Penske Automotive Group
PAG
$14.3B
| $292K | ﹤0.01% |
10,420
+271
| +3% | +$11.8K |
|
2196
First Community Bankshares
FCBC
$936M
| $291K | ﹤0.01% |
12,472
+314
| +3% | +$8.66K |
|
|
BAND
2197
Bandwidth Inc
BAND
$1.72B
| $289K | ﹤0.01% |
+4,297
| New | +$293K |
|
2198
Geron
GERN
$1B
| $288K | ﹤0.01% |
242,196
+58,800
| +32% | +$72K |
|
|
BFYT
2199
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $288K | ﹤0.01% |
12,871
-7,800
| -38% | -$185K |
|
|
TEN
2200
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $287K | ﹤0.01% |
79,667
+25,116
| +46% | +$211K |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.